Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Josef Jost"'
Publikováno v:
Productronic. 2/20/2024, p7-7. 1/3p.
Autor:
Reinhard, Tamara
Publikováno v:
Produktion. 4/30/2019, p44-47. 4p.
Autor:
Alain Kenfak-Foguena, Franziska Schöni-Affolter, Philippe Bürgisser, Andrea Witteck, Katharine E.A. Darling, Helen Kovari, Laurent Kaiser, John-Marc Evison, Luigia Elzi, Vanina Gurtner De La Fuente, Josef Jost, Darius Moradpour, Florence Abravanel, Jacques Izopet, Matthias Cavassini
Publikováno v:
Emerging Infectious Diseases, Vol 17, Iss 6, Pp 1074-1078 (2011)
We screened 735 HIV-infected patients in Switzerland with unexplained alanine aminotransferase elevation for hepatitis E virus (HEV) immunoglobulin G. Although HEV seroprevalence in this population is low (2.6%), HEV RNA can persist in patients with
Externí odkaz:
https://doaj.org/article/6ae7c09052754cb28eefb95030553906
Publikováno v:
Productronic. 9/3/2024, p22-23. 2p.
Publikováno v:
Circuits Assembly. May2007, Vol. 18 Issue 5, p12-12. 1/8p.
Publikováno v:
DE: Das Elektrohandwerk. 9/3/2024, p22-23. 2p.
Publikováno v:
Pflege. 13:152-159
Das berufsbedingte Expositions- und Infektionsrisiko für Hebammen/GeburtshelferInnen, sich bei der Begleitung von Wassergeburten von (möglicherweise unentdeckten) HIV-positiven Frauen mit HIV zu infizieren ist unbekannt. Ziel war die Quantifizierun
Autor:
Enos Bernasconi, Josef Jost, Mounir Ait-Khaled, Christine Katlama, Bonaventura Clotet, Keikawus Arastéh, Vincent Jeantils, Scott Purdon, Amy Cutrell, Andreas Plettenberg, Chris Stone
Publikováno v:
AIDS. 14:781-789
Objective: To compare the antiviral activity of abacavir (ABC) with stable background therapy (SBG) and SBG alone in antiretroviral therapy-experienced subjects as demonstrated by the proportion of subjects with plasma HIV-1 RNA ≤ 400 copies/ml, pl
Autor:
Helen, Kovari, Bruno, Ledergerber, Ulrich, Peter, Markus, Flepp, Josef, Jost, Patrick, Schmid, Alexandra, Calmy, Nicolas J, Mueller, Beat, Muellhaupt, Rainer, Weber, S, Yerly
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 49(4)
BACKGROUND: Noncirrhotic portal hypertension (NCPH) is a newly described life-threatening liver disease of unknown cause in human immunodeficiency virus (HIV)-infected persons. Postulated pathogenesis includes prolonged exposure to antiretroviral the
Autor:
Bruno Ledergerber, Josef Jost, Bernard Hirschel, Enos Bernasconi, Philippe Sudre, Patrick Francioli
Publikováno v:
Swiss medical weekly, vol. 131, no. 29-30, pp. 433-437
Swiss Medical Weekly, Vol. 131, No 29-30 (2001) pp. 433-437
Swiss Medical Weekly, Vol. 131, No 29-30 (2001) pp. 433-437
OBJECTIVE: To analyse the data from Swiss nationwide voluntary reporting on non-occupational HIV-postexposure prophylaxis (HIV-PEP) by prescribing physicians. METHODS: One hundred and seventy-six persons, who received antiretroviral prophylaxis for c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb9dce58e21f57a4aed218bf466cf5ca
https://serval.unil.ch/notice/serval:BIB_2BBD0D5C311D
https://serval.unil.ch/notice/serval:BIB_2BBD0D5C311D